Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers

• Autores principales: Shun-Long Ou (Autor), Jing Luo (Autor), Hua Wei (Autor), Xiao-Li Qin (Autor), Qian Jiang (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Evidence of efficacy and safety of programmed cell death 1 (PD-1) and programmed death ligand-1 (PD-L1) checkpoint inhibitors in oesophageal cancer (EC), gastric cancer (GC) and colorectal cancer (CRC) was inconsistent, obscuring their clinical application and decision-making. The aim of...